Crew Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Crew Capital Management's ABBV Position: Q3 2026 in Review
Crew Capital Management increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $24.9K and bringing the position to 8,648 shares worth $2.26M. The position accounts for 1.19% of the portfolio, ranked #21.
Crew Capital Management first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Crew Capital Management held 8,648 shares of AbbVie worth $2.26M as of Q3 2026.
- Crew Capital Management bought 97 AbbVie shares in Q3 2026, an estimated $24.9K.
- AbbVie made up 1.19% of Crew Capital Management's portfolio in Q3 2026, its #21 holding.
- Crew Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Crew Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.